409 related articles for article (PubMed ID: 30010081)
1. Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study.
Catalano A; Loddo S; Bellone F; Pecora C; Lasco A; Morabito N
Bone; 2018 Nov; 116():42-46. PubMed ID: 30010081
[TBL] [Abstract][Full Text] [Related]
2. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
[TBL] [Abstract][Full Text] [Related]
3. The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial.
Hooshmand S; Brisco JR; Arjmandi BH
Br J Nutr; 2014 Jul; 112(1):55-60. PubMed ID: 24780728
[TBL] [Abstract][Full Text] [Related]
4. The key role of proinflammatory cytokines, matrix proteins, RANKL/OPG and Wnt/β-catenin in bone healing of hip arthroplasty patients.
Cassuto J; Folestad A; Göthlin J; Malchau H; Kärrholm J
Bone; 2018 Feb; 107():66-77. PubMed ID: 29129760
[TBL] [Abstract][Full Text] [Related]
5. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects.
Corrado A; Neve A; Macchiarola A; Gaudio A; Marucci A; Cantatore FP
J Rheumatol; 2013 May; 40(5):684-94. PubMed ID: 23457386
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis.
Świerkot J; Gruszecka K; Matuszewska A; Wiland P
Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):397-404. PubMed ID: 25837853
[TBL] [Abstract][Full Text] [Related]
7. An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases.
Brunetti G; D'Amato G; Chiarito M; Tullo A; Colaianni G; Colucci S; Grano M; Faienza MF
World J Pediatr; 2019 Feb; 15(1):4-11. PubMed ID: 30343446
[TBL] [Abstract][Full Text] [Related]
8. Association of serum Dkk-1 levels with β-catenin in patients with postmenopausal osteoporosis.
Tian J; Xu XJ; Shen L; Yang YP; Zhu R; Shuai B; Zhu XW; Li CG; Ma C; Lv L
J Huazhong Univ Sci Technolog Med Sci; 2015 Apr; 35(2):212-218. PubMed ID: 25877354
[TBL] [Abstract][Full Text] [Related]
9. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.
Terpos E; Fragiadaki K; Konsta M; Bratengeier C; Papatheodorou A; Sfikakis PP
Clin Exp Rheumatol; 2011; 29(6):921-5. PubMed ID: 22032557
[TBL] [Abstract][Full Text] [Related]
10. The OPG/RANKL system and zinc ions are promoters of bone remodeling by osteoblast proliferation in postmenopausal osteoporosis.
Gurban CV; Mederle O
Rom J Morphol Embryol; 2011; 52(3 Suppl):1113-9. PubMed ID: 22119834
[TBL] [Abstract][Full Text] [Related]
11. Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis.
Stuss M; Sewerynek E; Król I; Stępień-Kłos W; Jędrzejczyk S
Endokrynol Pol; 2016; 67(2):174-84. PubMed ID: 26884284
[TBL] [Abstract][Full Text] [Related]
12. Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women.
Ostrowska Z; Kos-Kudła B; Marek B; Kajdaniuk D; Wołkowska-Pokrywa K
Postepy Hig Med Dosw (Online); 2011 Oct; 65():658-67. PubMed ID: 22100799
[TBL] [Abstract][Full Text] [Related]
13. Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Koukoulis G; Kita M; Avramidis A
Horm Metab Res; 2008 Apr; 40(4):281-5. PubMed ID: 18275008
[TBL] [Abstract][Full Text] [Related]
14. Serum β -Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis.
Xu XJ; Shen L; Yang YP; Zhu R; Shuai B; Li CG; Wu MX
Int J Endocrinol; 2013; 2013():534352. PubMed ID: 23710175
[TBL] [Abstract][Full Text] [Related]
15. Bariatric Roux-En-Y Gastric Bypass Surgery: Adipocyte Proteins Involved in Increased Bone Remodeling in Humans.
Biagioni MFG; Mendes AL; Nogueira CR; Leite CV; Gollino L; Mazeto GM
Obes Surg; 2017 Jul; 27(7):1789-1796. PubMed ID: 28091892
[TBL] [Abstract][Full Text] [Related]
16. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
17. Wnt Signaling-Related Osteokines and Transforming Growth Factors Before and After a Single Bout of Plyometric Exercise in Child and Adolescent Females.
Dekker J; Nelson K; Kurgan N; Falk B; Josse A; Klentrou P
Pediatr Exerc Sci; 2017 Nov; 29(4):504-512. PubMed ID: 28530511
[TBL] [Abstract][Full Text] [Related]
18. Pulsed electromagnetic fields inhibit bone loss in streptozotocin-induced diabetic rats.
Zhou J; Li X; Liao Y; Feng W; Fu C; Guo X
Endocrine; 2015 May; 49(1):258-66. PubMed ID: 25273319
[TBL] [Abstract][Full Text] [Related]
19. The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study.
Anagnostis P; Vakalopoulou S; Christoulas D; Paschou SA; Papatheodorou A; Garipidou V; Kokkoris P; Terpos E
Haemophilia; 2018 Mar; 24(2):316-322. PubMed ID: 29194852
[TBL] [Abstract][Full Text] [Related]
20. Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism.
Li H; Chen B; Pang G; Chen J; Xie J; Huang H
Pharm Biol; 2016; 54(1):111-7. PubMed ID: 25857587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
